Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LateTIME
NCT00684060Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Jul 2008
- Primary completion
- Aug 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow mononuclear cells in myocardial infarction (MI), left ventricular dysfunction, sponsored by UTHealth Houston. Started Jul 2008; status: completed.
02
Drugs
bone marrow mononuclear cells
03
Conditions
myocardial infarction (MI)left ventricular dysfunction
Beyond the preview
Go deeper on NCT00684060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684060.